Rare diseases
Investigational molecules
Locations
Study of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer
FranceStudy on the Safety and Effectiveness of 2-Hydroxyoleic Acid and Temozolomide with Radiotherapy for Patients with Newly Diagnosed Glioblastoma
FranceStudy on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
FranceStudy of Olaparib for Patients with Advanced BRCA-Mutated Ovarian Cancer After Initial Platinum-Based Chemotherapy
FranceStudy on the Effectiveness and Safety of Infigratinib for Children Aged 3 to 17 with Achondroplasia
FranceStudy on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB
FranceStudy on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata
FranceStudy on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy
FranceStudy of Relatlimab, Nivolumab, and Drug Combination for Patients with Advanced Cancer
FranceStudy of tucatinib, pertuzumab and trastuzumab combination for patients with HER2-positive metastatic breast cancer who have brain metastases after local therapy
FranceStudy of V940 and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
FranceStudy of BMS-986253 with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
